The singer-songwriter on his evolving solo career, the misguided side of fandom, and how he has never fallen out with his ...

Toby Tiangco; alignment of parties under the Alliance — Lakas-CMD, Nacionalista Party, National Unity Party, and the Nationalist People's Coalition — with the president's Partido Federal ng Pilipinas ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

Danuglipron, a weight-loss pill, won’t continue its stages of testing after a person in a clinical trial was reportedly injured. Pfizer plans to explore other obesity treatments for testing.

Several companies are working on potentially more convenient GLP-1 pills, including Lilly, which is expected to announce Phase 3 trial results for its drug orforglipron any day now.

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

(AP Photo/Yuki Iwamura) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

Read full article: License plate scanner helps Jacksonville police nab a man accused of lewd exhibition while following a minor Pfizer is ending the development of its potential once-daily pill ...

Pfizer signage is displayed at the Pfizer NYC Headquarters, Thursday, April 10, 2025, in New York. (AP Photo/Yuki Iwamura) (Yuki Iwamura, Copyright 2025 The ...